Advanced search
Publication Cover
Future Cardiology Volume 19, 2023 - Issue 4
Submit an article Journal homepage
95
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Ticagrelor and Primidone Interaction Masquerading as Dual Antiplatelet Therapy Noncompliance

Haris Patail1 Department of Internal MedicineUniversity of Connecticut School of Medicine263 Farmington Ave.FarmingtonCT06030Correspondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2342-9224
ORCID Icon,
Ali Ghani2 Department of Interventional CardiologyHartford Hospital80 Seymour St.HartfordCT06106USAUSA
,
Chad Nagle3 Department of PharmacyHartford Hospital80 Seymour St.HartfordCT06106USA
,
Raymond McKay2 Department of Interventional CardiologyHartford Hospital80 Seymour St.HartfordCT06106USAUSA
,
Asad Rizvi2 Department of Interventional CardiologyHartford Hospital80 Seymour St.HartfordCT06106USAUSA
&
Jawad Haider2 Department of Interventional CardiologyHartford Hospital80 Seymour St.HartfordCT06106USAUSA
Pages 189-195 | Received 21 Jan 2023, Accepted 16 May 2023, Published online: 14 Jun 2023

References

  • Lenkapothula N , CascellaM. Primidone. In: StatPearls.StatPearls Publishing (2022). www.ncbi.nlm.nih.gov/books/NBK562297/
  • Koller WC , RoyseVL. Efficacy of primidone in essential tremor. Neurology36(1), 121–124 (1986).
  • Fincham RW , SchotteliusDD, SahsAL. The influence of diphenylhydantoin on primidone metabolism. Arch. Neurol.30(3), 259–262 (1974).
  • Reddy M , YangRS, AndersenME, ClewellHJ III. Chapter 10. In: Physiologically Based Pharmacokinetic Modeling: Science and Applications.John Wiley & Sons, NJ, USA, 292–293 (2005).
  • Bentué-Ferrer D , VerdierMC, TributO. Therapeutic drug monitoring of primidone and phenobarbital. Therapie67(4), 381–390 (2012).
  • Mauri L , KereiakesDJ, YehRWet al. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N. Engl. J. Med.371(23), 2155–2166 (2014).
  • Kamran H , JneidH, KayaniWTet al. Oral antiplatelet therapy after acute coronary syndrome: a review. J. Am. Med. Assoc.325(15), 1545–1555 (2021).
  • Kabil MF , AboDena AS, El-SherbinyIM. Ticagrelor. Profiles Drug Subst. Excip. Relat. Methodol.47, 91–111 (2022).
  • Bonaca MP , BhattDL, CohenMet al. Long-term use of ticagrelor in patients with prior myocardial infarction. N. Engl. J. Med.372(19), 1791–1800 (2015).
  • Teng R , ButlerK. The effect of ticagrelor on the metabolism of midazolam in healthy volunteers. Clin. Ther.35(7), 1025–1037 (2013).
  • Akkaif MA , NgML, SKAbdul Kader MA, DaudNAA, Sha'abanA, IbrahimB. A review of the effects of ticagrelor on adenosine concentration and its clinical significance. Pharmacol. Rep.73(6), 1551–1564 (2021).
  • Adamski P , BuszkoK, SikoraJet al. Metabolism of ticagrelor in patients with acute coronary syndromes. Sci. Rep.8(1), 11746 (2018).
  • Dobesh PP , OestreichJH. Ticagrelor: pharmacokinetics, pharmacodynamics, clinical efficacy, and safety. Pharmacotherapy34(10), 1077–1090 (2014).
  • Bates ER , LauWC, AngiolilloDJ. Clopidogrel–drug interactions. J. Am. Coll. Cardiol.57(11), 1251–1263 (2011).
  • Wang ZY , ChenM, ZhuLLet al. Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy. Ther. Clin. Risk Manag.11, 449–467 (2015).
  • Wiviott SD , AntmanEM. Clopidogrel resistance: a new chapter in a fast-moving story. Circulation109(25), 3064–3067 (2004).
  • Matetzky S , ShenkmanB, GuettaVet al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation109(25), 3171–3175 (2004).
  • De Miguel A , IbanezB, BadimónJJ. Clinical implications of clopidogrel resistance. Thromb. Haemost.100(2), 196–203 (2008).
  • van Werkum JW , HarmszeAM, ElsenbergEHAM, BoumanHJ, ten BergJM, HackengCM. The use of the VerifyNow system to monitor antiplatelet therapy: a review of the current evidence. Platelets19(7), 479–488 (2008).
  • Jeong YH , BlidenKP, AntoninoMJ, ParkKS, TantryUS, GurbelPA. Usefulness of the VerifyNow P2Y12 assay to evaluate the antiplatelet effects of ticagrelor and clopidogrel therapies. Am. Heart J.164(1), 35–42 (2012).
  • Kim YG , SuhJW, ParkJJet al. Different influences of hematocrit on the results of two point-of-care platelet function tests, the VerifyNow assay and multiple electrode platelet aggregometry. PLOS ONE9(11), e114053 (2014).
  • Kakouros N , KicklerTS, LawsKM, RadeJJ. Hematocrit alters VerifyNow P2Y12 assay results independently of intrinsic platelet reactivity and clopidogrel responsiveness. J. Thromb. Haemost.11(10), 1814–1822 (2013).
  • Danielak D , KomosaA, TomczakAet al. Determinants of high on-treatment platelet reactivity and agreement between VerifyNow and Multiplate assays. Scand. J. Clin. Lab. Invest.77(3), 190–198 (2017).
  • Yazji K , AbdulF, ElangovanSet al. Baseline anemia in patients undergoing percutaneous coronary intervention after an acute coronary syndrome-A paradox of high bleeding risk, high ischemic risk, and complex coronary disease. J. Interv. Cardiol.30(5), 491–499 (2017).
  • Gragnano F , MehranR, BrancaMet al. P2Y12 inhibitor monotherapy or dual antiplatelet therapy after complex percutaneous coronary interventions. J. Am. Coll. Cardiol.81(6), 537–552 (2023).
  • Brilinta™ (ticagrelor) Tablets: A P2Y(12) platelet inhibitor indicated to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS). PT37(4 section 2), 4–18 (2012). https://pubmed.ncbi.nlm.nih.gov/22605912/

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.